View on Pubmed.gov 7805037 View on doi.org
The novel activation of ABL by fusion to an ets-related gene, TEL.
- Leukaemia Research Fund Centre, Institute of Cancer Research, London, United Kingdom.
Abstract
In human leukemia, activation of the ABL proto-oncogene locus on chromosome 9 most commonly occurs as a result of its fusion to the BCR locus on chromosome 22. The resulting chimeric protein displays an elevated tyrosine kinase activity. We have identified a novel activation of ABL which involves a gene located on chromosome 12, designated TEL. Like BCR, TEL is fused in-frame with ABL and produces a fusion protein with an elevated tyrosine kinase activity when assayed in an immune complex. The amino-terminal sequences of TEL encode a helix-loop-helix motif which may mediate dimerization.
References
Cited by 289 citations (total)
Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.
Characterization of NERF, a novel transcription factor related to the Ets factor ELF-1.
Electronic publication date September 1, 1996
P Oettgen [...] T A Libermann et al.
We have cloned the gene for a novel Ets-related transcription factor, new Ets-related factor (NERF), from human spleen, fetal liver,...
Journal Article Research Support, U.S. Gov't, P.H.S.
A chimeric receptor/oncogene that can be regulated by a ligand in vitro and in vivo.
Electronic publication date October 6, 1997
K Okuda [...] J D Griffin et al.
The BCR/ABL oncogene encodes an activated tyrosine kinase that causes human chronic myelogenous leukemia. The mechanism of transformation, however, is...